Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 25 2024

Full Issue

Study Finds Twice-Yearly Shot 100% Effective At Blocking HIV

In a study of 5,000 young women and girls in Africa, none of the patients who received the shots contracted HIV. NPR notes the trial generated controversy at the AIDS 2024 conference and prompted an expert group to recommend halting the blind trial and giving the lenacapavir drug to all participants.

The Washington Post: Twice-A-Year Shot Offers 100 Percent HIV Protection, Study Finds 

A twice-yearly injection could help prevent HIV infections, according to the results of a new study described by medical experts as a breakthrough. In a randomized trial involving more than 5,000 young women and girls in South Africa and Uganda, none of those who received the prevention shots contracted HIV. The results were published in the New England Journal of Medicine on Wednesday. (Pannett, 7/25)

NPR: HIV Preventive Strategy Sparks Interest -- And Protests -- At AIDS Conference

A new way to prevent HIV infection is generating great buzz -- and more than a bit of controversy -- at this week’s AIDS 2024 Conference in Munich. ... These results were significant enough for the Data Monitoring Committee -- an independent group of experts appointed to assess the progress of clinical trials -- to recommend that Gilead halt its blinded trial and offer lenacapavir to all study participants. On June 20, Gilead announced these results, and now, all participants can choose to receive the injection. (Barros Guinle, 7/24)

In other health and wellness news —

Bloomberg: What The Temperature Doesn’t Tell You About Extreme Heat’s Hazards

After its nationwide rollout on Earth Day, the HeatRisk forecasting tool is getting a real-world test as deadly temperatures stress much of the US. Created by the US Centers for Disease Control and Prevention and the National Oceanic and Atmospheric Administration, HeatRisk combines public health data and weather forecasts to create a map of threatening heat across the country. Similar to how tornadoes and hurricanes are categorized, the tool ranks heat waves on a scale of 0 to 4 based on how dangerous they are. (Battle Abdelal, 7/24)

Fox News: Seniors More Likely To Miss Doctors’ Appointments In Extreme Heat Or Cold, Study Finds

Whether it’s the dog days of summer or a cold snap in the dead of winter, extreme temperatures tend to bring people’s activities to a halt — including doctors’ appointments. Seniors in particular are more likely to skip their scheduled medical visits if it’s too hot or too cold, according to a study from the American Journal of Preventative Medicine. On days that are 90 degrees or hotter, for every 1 degree increase in temperature, the rate of missed appointments rises by 0.64%, as reported by researchers at the Drexel University College of Medicine in Philadelphia, Pennsylvania. (Rudy, 7/24)

USA Today: What Is The Fittest City In America? New Rankings Revealed

Living near parks, bike trails and green space is as important as being motivated when it comes to achieving your fitness goals, experts say. Not all communities provide such amenities. Those that hit all the marks showed up in the annual American Fitness Index released Tuesday by the American College of Sports Medicine (ACSM) and the Elevance Health Foundation. The index ranks the nation’s 100 largest cities on 33 personal and community health indicators. (Alltucker, 7/23)

USA Today: Diamond Shruumz Mushroom Recall: 2 Possible Deaths, Cases In 28 States

Health officials are investigating a possible second death linked to a brand of recalled microdosing mushroom-infused edibles. Since the Food and Drug Administration's initial June warning about Diamond Shruumz-brand Microdosing Chocolate Bars – and some users having bad reactions including seizures and vomiting – the agency has tracked 74 cases in 28 states. (Snider, 7/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF